Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
暂无分享,去创建一个
Ramanan Laxminarayan | Gerardo Alvarez-Uria | Mike Sharland | Sreeram Subramanian | Srinivas Murki | S. Gandra | R. Laxminarayan | M. Sharland | Y. Hsia | S. Murki | Yingfen Hsia | S. Subramanian | G. Alvarez-Uria | Sumanth Gandra | Ravishankar Kanithi | Anita Sharma | Dhanya Dharmapalan | Anil Kumar Vasudevan | Onkaraiah Tunga | Akhila Akula | Sanjeev K. Singh | Dasaratha R. Jinka | Ashok K. Chikkappa | Hemasree Kandraju | Sanjeev Singh | A. Akula | D. Jinka | Anita Sharma | Hemasree Kandraju | Ravishankar Kanithi | Onkaraiah Tunga | D. Dharmapalan
[1] S. Chatterjee,et al. Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India , 2007, Pharmacoepidemiology and drug safety.
[2] C. Tebé,et al. Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia , 2017, Antimicrobial Agents and Chemotherapy.
[3] J. Sohn,et al. Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli. , 2017, International journal of antimicrobial agents.
[4] V. Pandit,et al. Antibiotic Prescribing Pattern in a Tertiary Level Neonatal Intensive Care Unit. , 2015, Journal of clinical and diagnostic research : JCDR.
[5] H. Goossens,et al. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. , 2016, The Journal of antimicrobial chemotherapy.
[6] Megha Sharma,et al. Up to 89% of neonates received antibiotics in cross‐sectional Indian study including those with no infections and unclear diagnoses , 2017, Acta paediatrica.
[7] D. Paterson,et al. Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials , 2017, The Journal of antimicrobial chemotherapy.
[8] M. Sharland,et al. High Reported Rates of Antimicrobial Resistance in Indian Neonatal and Pediatric Blood Stream Infections , 2017, Journal of the Pediatric Infectious Diseases Society.
[9] Ramanan Laxminarayan,et al. Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016 , 2017, Antibiotics.
[10] S. Gandra,et al. Impact of antibiotic policy on antibiotic consumption in a neonatal intensive care unit in India , 2017, Indian Pediatrics.
[11] Paul Newell,et al. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Charu,et al. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. , 2016, The Lancet. Global health.
[13] Z. Bhutta,et al. Antimicrobial resistance-a threat to neonate survival. , 2016, The Lancet. Global health.
[14] S. Cosgrove,et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.